CCNE1 and breast cancer: Many researches have presented that Cyclin E1 could mediate the progression of many tumors, such as hepatocellular carcinoma (Sonntag et al., 2018; Xu et al., 2019), ovarian cancer (Au-Yeung et al., 2017), and breast cancer (Turner et al., 2019).